AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies
Go back to AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies| (NASDAQ: ANAB) | Delayed: 55.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.16 | 52 Week High | $ | |||
| Open | $55.16 | 52 Week Low | $ | |||
| Day High | $55.16 | P/E | N/A | |||
| Day Low | $55.16 | EPS | $ | |||
| Volume | 103 | |||||

